title: Mouse placental cells secrete immunoreactive growth hormone-releasing factor.
abstract: The initial objective of this study was to establish a placental cell culture system in which the secretion of mouse growth hormone-releasing factor (mGHRF) could be examined during a several-day period. To determine when during pregnancy placental cells begin to express mGHRF, Northern blot analysis was carried out on total RNA from placentas collected on Days 6, 9, 11, 13, 15, 17, and 18 of pregnancy. Mouse GHRF mRNA could be detected as early as Day 11 of pregnancy. Its steady-state levels increased to maximum values on Days 15-17 and then declined slightly on Day 18. Placentas from Day 12 of pregnancy were selected for cell culture. The basal zone and labyrinth were dispersed in collagenase, and the cells were fractionated on a Percoll gradient. Two bands of cells were selected for further study. Both released significant amounts of immunoreactive mGHRF during a 5-day culture period. Effects of prolonged exposure of the cells to 8-bromo-cAMP and to agents that elevate intracellular cAMP concentration were then examined. Treatment of the cells with 0.5 mM 8-bromo-cAMP resulted in a significant decrease in the mGHRF concentration of the medium by the second day of culture. Mouse GHRF secretion was also inhibited by treatment of the cells with 100 ng/ml cholera toxin or 0.1 mM forskolin. The effect of 8-bromo-cAMP was concentration-dependent, with 0.1 mM being the lowest concentration that was active. 8-Bromo-cAMP treatment also reduced the steady-state level of mGHRF mRNA in the cells.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Biology, University of California, Santa Cruz 95064.
authors.forename: H
authors.initials: H
authors.lastname: Endo
authors.forename: M
authors.initials: M
authors.lastname: Yamaguchi
authors.forename: R
authors.initials: R
authors.lastname: Farnsworth
authors.forename: G
authors.initials: G
authors.lastname: Thordarson
authors.forename: L
authors.initials: L
authors.lastname: Ogren
authors.forename: F J
authors.initials: FJ
authors.lastname: Alonso
authors.forename: M
authors.initials: M
authors.lastname: Sakata
authors.forename: K
authors.initials: K
authors.lastname: Hirota
authors.forename: F
authors.initials: F
authors.lastname: Talamantes
mesh_terms: D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D015152:Blotting, Northern; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005786:Gene Expression Regulation; D013007:Growth Hormone-Releasing Hormone / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D010920:Placenta / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D011863:Radioimmunoassay
chemical_list: D012333:RNA, Messenger; D015124:8-Bromo Cyclic Adenosine Monophosphate; D013007:Growth Hormone-Releasing Hormone; D000242:Cyclic AMP